{"id":"W4399322695","doi":"10.1200/jco.2024.42.16_suppl.596","title":"Neoadjuvant pegylated liposomal doxorubicin-containing chemotherapy in combination with trastuzumab and pertuzumab in patients with HER2-positive early breast cancer: A randomized phase II study (METIS).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pertuzumab; Trastuzumab; Oncology; Breast cancer; Chemotherapy; Internal medicine; Doxorubicin; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001549341,0.001404779,0.002780079,0.0005155514,0.0003195553,0.0006767762,0.0006861293,0.0009589148,0.00272377],"category_scores_gemma":[0.0007573539,0.000784358,0.001244742,0.0004976065,0.001069932,0.0008812979,0.0004078456,0.001858882,0.000435273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007567104,"about_ca_system_score_gemma":0.001578732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000530874,"about_ca_topic_score_gemma":0.001431932,"domain_scores_codex":[0.9995584,0.0002289127,0.00003129165,0.00007089064,0.0000397546,0.00007071265],"domain_scores_gemma":[0.9994931,0.00007957155,0.0001061483,0.00004452658,0.00002989482,0.0002466699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9053931,0.04936939,0.0032157,0.0006350736,0.0008388427,0.00007459756,0.00009557493,0.0007426547,0.01115172,0.0001173581,0.0006190501,0.02774702],"study_design_scores_gemma":[0.7247205,0.2696353,0.003151627,0.00002070806,0.0004007033,0.00003986184,0.00002016999,0.0004614186,0.0008565985,0.00005370211,0.000627499,0.00001186359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934344,0.001759557,0.000381708,0.0002409428,0.0001570926,0.003082484,0.0002648637,0.00003970852,0.0006392586],"genre_scores_gemma":[0.9876562,0.002298081,0.001630132,0.0006564727,0.0003129069,0.005270484,0.000807843,0.00001271987,0.001355097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002780079,"threshold_uncertainty_score":0.009111941,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03680764509453337,"score_gpt":0.4450239036082301,"score_spread":0.4082162585136967,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}